Dawn A. Delfín

796 total citations
21 papers, 641 citations indexed

About

Dawn A. Delfín is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Dawn A. Delfín has authored 21 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Epidemiology. Recurrent topics in Dawn A. Delfín's work include Trypanosoma species research and implications (8 papers), Muscle Physiology and Disorders (7 papers) and Research on Leishmaniasis Studies (7 papers). Dawn A. Delfín is often cited by papers focused on Trypanosoma species research and implications (8 papers), Muscle Physiology and Disorders (7 papers) and Research on Leishmaniasis Studies (7 papers). Dawn A. Delfín collaborates with scholars based in United States, Switzerland and Belgium. Dawn A. Delfín's co-authors include Jill A. Rafael‐Fortney, Karl A. Werbovetz, Paul M.L. Janssen, Ying Xu, Benjamin D. Canan, Kevin E. Schill, Manar M. Salem, Gautam Bhattacharya, Subha V. Raman and Muthu Periasamy and has published in prestigious journals such as Circulation, PLoS ONE and Journal of Applied Physiology.

In The Last Decade

Dawn A. Delfín

21 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn A. Delfín United States 15 347 165 148 141 137 21 641
José Manuel García-Castellano Spain 14 277 0.8× 98 0.6× 20 0.1× 44 0.3× 44 0.3× 26 684
Klas Pekkari Sweden 14 566 1.6× 28 0.2× 74 0.5× 25 0.2× 23 0.2× 20 884
Patrick Neubert Germany 14 343 1.0× 74 0.4× 13 0.1× 47 0.3× 53 0.4× 26 611
Olof Danielsson Sweden 12 231 0.7× 21 0.1× 55 0.4× 97 0.7× 13 0.1× 34 587
Toshihiko Maruyama Japan 7 165 0.5× 45 0.3× 8 0.1× 92 0.7× 61 0.4× 7 388
Shujun Yang China 13 540 1.6× 47 0.3× 52 0.4× 48 0.3× 8 0.1× 31 735
Youmin Wang China 14 147 0.4× 8 0.0× 42 0.3× 98 0.7× 25 0.2× 45 459
Jutamas Suwanpradid United States 15 180 0.5× 17 0.1× 16 0.1× 39 0.3× 31 0.2× 18 555
Elizabeth C. Hinchy United Kingdom 8 366 1.1× 11 0.1× 46 0.3× 91 0.6× 10 0.1× 11 602

Countries citing papers authored by Dawn A. Delfín

Since Specialization
Citations

This map shows the geographic impact of Dawn A. Delfín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn A. Delfín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn A. Delfín more than expected).

Fields of papers citing papers by Dawn A. Delfín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn A. Delfín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn A. Delfín. The network helps show where Dawn A. Delfín may publish in the future.

Co-authorship network of co-authors of Dawn A. Delfín

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn A. Delfín. A scholar is included among the top collaborators of Dawn A. Delfín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn A. Delfín. Dawn A. Delfín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delfín, Dawn A., et al.. (2019). The Extracellular Matrix Protein ABI3BP in Cardiovascular Health and Disease. Frontiers in Cardiovascular Medicine. 6. 23–23. 20 indexed citations
2.
3.
Zhang, Liwen, Edgar Fischer, Von G. Samedi, et al.. (2016). Altered protein levels in the isolated extracellular matrix of failing human hearts with dilated cardiomyopathy. Cardiovascular Pathology. 26. 12–20. 15 indexed citations
4.
Pant, Meghna, Danesh H. Sopariwala, Naresh C. Bal, et al.. (2015). Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy. PLoS ONE. 10(4). e0123875–e0123875. 57 indexed citations
5.
Delfín, Dawn A., Neha Rastogi, Honglan Wang, et al.. (2014). Claudin-5 levels are reduced from multiple cell types in human failing hearts and are associated with mislocalization of ephrin-B1. Cardiovascular Pathology. 24(3). 160–167. 22 indexed citations
6.
Taglieri, Domenico M., Dawn A. Delfín, & Michelle M. Monasky. (2013). Cholesterol regulation of PIP2: why cell type is so important. Frontiers in Physiology. 3. 492–492. 9 indexed citations
7.
8.
Delfín, Dawn A., Ying Xu, Kevin E. Schill, et al.. (2012). Sustaining Cardiac Claudin-5 Levels Prevents Functional Hallmarks of Cardiomyopathy in a Muscular Dystrophy Mouse Model. Molecular Therapy. 20(7). 1378–1383. 22 indexed citations
9.
Delfín, Dawn A., Ying Xu, Jennifer M. Peterson, et al.. (2011). Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy. Journal of Translational Medicine. 9(1). 68–68. 32 indexed citations
10.
Peterson, Jennifer M., William O. Kline, Benjamin D. Canan, et al.. (2011). Peptide-Based Inhibition of NF-κB Rescues Diaphragm Muscle Contractile Dysfunction in a Murine Model of Duchenne Muscular Dystrophy. Molecular Medicine. 17(5-6). 508–515. 44 indexed citations
11.
Xu, Ying, Dawn A. Delfín, Jill A. Rafael‐Fortney, & Paul M.L. Janssen. (2010). Lengthening-contractions in isolated myocardium impact force development and worsen cardiac contractile function in the mdx mouse model of muscular dystrophy. Journal of Applied Physiology. 110(2). 512–519. 6 indexed citations
12.
Fotie, Jean, Marcel Kaiser, Dawn A. Delfín, et al.. (2010). Antitrypanosomal Activity of 1,2-Dihydroquinolin-6-ols and Their Ester Derivatives. Journal of Medicinal Chemistry. 53(3). 966–982. 61 indexed citations
13.
Varian, Kenneth D., Anusak Kijtawornrat, Subash Gupta, et al.. (2009). Impairment of Diastolic Function by Lack of Frequency-Dependent Myofilament Desensitizationin Rabbit Right Ventricular Hypertrophy. Circulation Heart Failure. 2(5). 472–481. 33 indexed citations
14.
Delfín, Dawn A., Rachel Morgan, Xiaohua Zhu, & Karl A. Werbovetz. (2008). Redox-active dinitrodiphenylthioethers against Leishmania: Synthesis, structure–activity relationships and mechanism of action studies. Bioorganic & Medicinal Chemistry. 17(2). 820–829. 36 indexed citations
15.
George, Tesmol G., Rachel Morgan, Kiran V. Mahasenan, et al.. (2007). Synthesis, biological evaluation, and molecular modeling of 3,5-substituted-N1-phenyl-N4,N4-di-n-butylsulfanilamides as antikinetoplastid antimicrotubule agents. Bioorganic & Medicinal Chemistry. 15(18). 6071–6079. 21 indexed citations
16.
George, Tesmol G., Jayaseharan Johnsamuel, Dawn A. Delfín, et al.. (2006). Antikinetoplastid antimitotic activity and metabolic stability of dinitroaniline sulfonamides and benzamides. Bioorganic & Medicinal Chemistry. 14(16). 5699–5710. 14 indexed citations
17.
Delfín, Dawn A., et al.. (2006). Activity of and Initial Mechanistic Studies on a Novel Antileishmanial Agent Identified through in Silico Pharmacophore Development and Database Searching. Journal of Medicinal Chemistry. 49(14). 4196–4207. 9 indexed citations
18.
Bhattacharya, Gautam, et al.. (2004). Synthesis and Antitubulin Activity of N- and N4-Substituted 3,5-Dinitro Sulfanilamides against African Trypanosomes and Leishmania. Journal of Medicinal Chemistry. 47(7). 1823–1832. 42 indexed citations
19.
Werbovetz, Karl A., Dan L. Sackett, Dawn A. Delfín, et al.. (2003). Selective Antimicrotubule Activity of N1-Phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5) against Kinetoplastid Parasites. Molecular Pharmacology. 64(6). 1325–1333. 62 indexed citations
20.
Hua, Duy H., Masafumi Tamura, Masahiro Egi, et al.. (2003). Antiprotozoal activities of symmetrical bishydroxamic acids. Bioorganic & Medicinal Chemistry. 11(20). 4357–4361. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Manuel García-Castellano Breakdown of academic impact, for papers by Klas Pekkari Breakdown of academic impact, for papers by Patrick Neubert Breakdown of academic impact, for papers by Olof Danielsson Breakdown of academic impact, for papers by Toshihiko Maruyama Breakdown of academic impact, for papers by Shujun Yang Breakdown of academic impact, for papers by Youmin Wang Breakdown of academic impact, for papers by Jutamas Suwanpradid Breakdown of academic impact, for papers by Elizabeth C. Hinchy
Rankless by CCL
2026